Literature DB >> 20084142

Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy.

.   

Abstract

Entities:  

Year:  2001        PMID： 20084142      PMCID： PMC2805976          DOI： 10.1093/pch/6.9.685

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  25 in total

1.  ACOG committee opinion. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Number 219, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1999-09       Impact factor: 3.561

2.  Should there be routine testing for human immunodeficiency virus infection in pregnancy?

Authors: 
Journal:  Can J Infect Dis       Date:  1994-09

3.  The case for rapid HIV testing during labor.

Authors:  H Minkoff; M J O'Sullivan
Journal:  JAMA       Date:  1998-06-03       Impact factor: 56.272

4.  Care of the infant born to an HIV-positive mother.

Authors: 
Journal:  Paediatr Child Health       Date:  2000-04       Impact factor: 2.253

5.  Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-01-30

6.  Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women.

Authors:  J P McGowan; M Crane; A A Wiznia; S Blum
Journal:  Obstet Gynecol       Date:  1999-11       Impact factor: 7.661

7.  The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

Authors:  W Andiman; Y Bryson; M de Martino; M Fowler; D Harris; C Hutto; B Korber; A Kovacs; S Landesman; M Lindsay; N Lapointe; L Mandelbrot; M-L Newell; H Peavy; J Read; C Rudin; A Semprini; R Simonds; R Tuomala
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

8.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

9.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

10.  Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Authors:  M Culnane; M Fowler; S S Lee; G McSherry; M Brady; K O'Donnell; L Mofenson; S L Gortmaker; D E Shapiro; G Scott; E Jimenez; E C Moore; C Diaz; P M Flynn; B Cunningham; J Oleske
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272
View more
  2 in total

1.  Testing for HIV infection in pregnancy.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-03       Impact factor: 2.253

2.  Prenatal Screening for HIV in Nova Scotia: Survey of Postpartum Women and Audit of Current Prenatal Screening Practices.

Authors:  Mark Downing; Laura Youden; Beth A Halperin; Heather Scott; Bruce Smith; Scott A Halperin
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-07       Impact factor: 2.471
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.